| Preview | Company (Stock code) | Event | Presenter |
|---|---|---|---|
 | HVIVO PLC (HVO) |
hVIVO - Positive topline results from client Phase 2b field study Dr. Andrew Catchpole - Chief Scientific Officer, hVIVO Mon, 30 Jun 2025 02:00 pm (UK time) |
|